LEGGETT & PLATT INC (LEG)       33.35  -0.73 (-2.14%)

33.35  -0.73 (-2.14%)

US5246601075 - Common Stock - After market: 33.3 -0.05 (-0.15%)


Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to LEG. LEG was compared to 67 industry peers in the Household Durables industry. LEG has a medium financial health rating, its profitability is only medium as well. While showing a medium growth rate, LEG is valued expensive at the moment.




Profitability

Profitability Rating

4

LEG's Return On Assets of 7.42% is in line with the rest of the industry. The industry average Return On Assets is 7.56%.
LEG has a Return On Equity of 24.06%. This is comparable to the industry average of 21.29%.

LEG's Profit Margin of 7.31% is in line with the rest of the industry. The industry average Profit Margin is 7.31%.
The Piotroski-F score of LEG is 5.00. This is a neutral score and indicates average health and profitability for LEG.
VS Industry

ROA (7.42%) VS Industry: 48% outperformed.

-86.15
35.69

ROE (24.06%) VS Industry: 58% outperformed.

1.33
73.03

Profit Margin (7.31%) VS Industry: 50% outperformed.

-384.05
31.70

Valuation

Valuation Rating

2

The Price/Earnings Ratio is 11.74, which indicates a very decent valuation of LEG.
The Forward Price/Earnings Ratio of 11.92 indicates a rather cheap valuation of LEG.
When comparing the current price to the book value of LEG, we can conclude it is valued correctly. It is trading at 2.74 times its book value.
Compared to an average industry Price/Earning Ratio of 6.40, LEG is valued more expensive than its industry peers. On top of this 82% of the companies listed in the same industry are cheaper than LEG!

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
When comparing the price book ratio of LEG to the average industry price book ratio of 1.13, LEG is valued more expensive than its industry peers. 89% of the companies listed in the same industry are valued cheaper.
When comparing the Enterprise Value to EBITDA ratio of LEG to the average industry ratio of 5.92, LEG is valued more expensive than its industry peers.
VS Industry

Price/Earnings (11.74) VS Industry: 18% outperformed.

47.00
0.92

Price/Book (2.74) VS Industry: 11% outperformed.

5.56
0.16

Enterprise Value/ EBITDA (8.47) VS Industry: 26% outperformed.

38.13
1.87

Growth

Growth Rating

4

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
Looking at the last year, LEG shows a quite strong growth in Revenue. The Revenue has grown by 10.36% in the last year.
The earnings per share for LEG have decreased by -0.70% in the last year.
LEG shows a small growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 2.23% yearly.

Based on estimates for the next 5 years, LEG will show a small growth in Earnings Per Share. The EPS will grow by 3.89% on average per year.
The Revenue has been growing slightly by 6.23% on average over the past 5 years.
The Revenue is expected to grow by 3.11% on average over the next 5 years.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS2.23% 3.74% -0.7% -1.72% 0.32% 3.08% 3.89%
Revenue6.23% 5.91% 10.36% 5.81% 3.97% 3.72% 3.11%

Health

Health Rating

4

An Altman-Z score of 3.12 indicates that LEG is not in any danger for bankruptcy at the moment.
A Current Ratio of 1.57 indicates that LEG should not have too much problems paying its short term obligations.
The Altman-Z score is in line with the industry averages, which is at 2.88.
LEG has a Piotroski-F score of 5.00. This indicates an average health and profitability for LEG.

When comparing the Current Ratio of LEG to the average industry Current Ratio of 2.13, LEG is less able to pay its short term obligations than its industry peers.
A Quick Ratio of 0.80 indicates that LEG may have some problems paying its short term obligations.
When comparing the Quick Ratio of LEG to the average industry Current Ratio of 0.95, LEG is less able to pay its short term obligations than its industry peers.
LEG has one of the worst Debt to Equity ratios in its industry. 91% of its industry peers require less debt for financing their operations.
VS Industry

Debt/Equity (1.11) VS Industry: 9% outperformed.

3.95
0.00

Quick Ratio (0.8) VS Industry: 40% outperformed.

0.43
18.83

Current Ratio (1.57) VS Industry: 26% outperformed.

0.60
20.59

Altman-Z (3.12) VS Industry: 55% outperformed.

-11.69
13.56

Dividend

Dividend Rating

8

LEG has a Yearly Dividend Yield of 4.85%, which is a nice return.
Compared to an average industry Dividend Yield of 2.50, LEG pays a better dividend. On top of this LEG pays more dividend than 81% of the companies listed in the same industry.
LEG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.48.
LEG has been paying a dividend for at least 10 years, so it has a reliable track record.

The dividend of LEG has a limited annual growth rate of 3.44%.
57.71% of the earnings are spent on dividend by LEG. This is a bit on the high side, but may be sustainable.
LEG's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (4.85%) VS Industry: 81% outperformed.

0.63
6.81
LEG Daily chart

LEGGETT & PLATT INC33.35

NYSE:LEG (9/26/2022, 7:04:00 PM)-0.73 (-2.14%)

After market: 33.3 -0.05 (-0.15%)

Chartmill FA Rating
GICS Sector Consumer Discretionary
GICS IndustryGroup Consumer Durables & Apparel
GICS Industry Household Durables
Earnings (Last) 08-01 2022-08-01/amc Earnings (Next) 10-31 2022-10-31
Ins Owners 1.4% Inst Owners 74.33%
Market Cap 4.42B Analysts 72.5
Valuation
PE 11.74 Fwd PE 11.92
PEG (NY) N/A PEG (5Y) 5.27
P/S 0.83 P/B 2.74
EV/EBITDA 8.47
Dividend
Dividend Yield 4.85% Dividend Growth 3.44%
DP 57.71% Ex-Date 09-14 2022-09-14 (0.44)
Growth
EPS 1Y -0.7% EPS 3Y 3.74%
EPS 5Y 2.23% EPS growth Q2Q 6.06%
EPS Next Y -1.72% EPS Next 2Y 0.32%
EPS Next 3Y 3.08% EPS Next 5Y 3.89%
Revenue growth 1Y 10.36% Revenue growth 3Y 5.91%
Revenue growth 5Y 6.23% Revenue growth Q2Q 5.09%
Revenue Next Year 5.81% Revenue Next 2Y 3.97%
Revenue Next 3Y 3.72% Revenue Next 5Y 3.11%
Health
Current Ratio 1.57 Quick Ratio 0.8
Altman-Z 3.12 F-Score 5
Debt/Equity 1.11
Profitability
ROA 7.42% ROE 24.06%
ROIC 24.17% ROICg 11.18%
PM 7.31 OM 10.64
Asset Turnover 1.01

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA